Jamaica’s outlook revised to stable by Fitch after hurricane
Cathie Wood's ARK ETF published their daily trades for Friday, November 14th, 2025, showcasing a mix of strategic buys and sells across various sectors. The most significant move was the sale of 1,876,328 shares of Pinterest Inc (NYSE:PINS) through the ARKK ETF, totaling $50,229,300. This continues a trend of reducing exposure to Pinterest, following a sale of 572,735 shares just the day before.
On the buying side, ARK increased its holdings in Bitmine Immersion Technologies Inc (NASDAQ:BMNR) by purchasing 169,407 shares across its ARKK, ARKW, and ARKF ETFs, amounting to a total value of $6,195,213. This adds to the previous day's acquisition of 242,347 shares, indicating a growing interest in the company.
Twist Bioscience Corp (NASDAQ:TWST) also saw a significant purchase with ARK acquiring 184,505 shares, valued at $5,516,699. This purchase follows consistent buying over the past week, highlighting ARK's confidence in the company's potential.
In the biotech space, ARK continued to invest in Beam Therapeutics Inc (NASDAQ:BEAM), buying 138,677 shares for $3,003,743. This follows a substantial purchase earlier in the week, suggesting a bullish outlook on the company's future.
Among smaller trades, ARK added 51,233 shares of Tempus AI Inc (NASDAQ:TEM) totaling $3,480,770, and 40,269 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) valued at $2,058,148. Both companies have been frequent additions to ARK's portfolio recently.
On the selling front, ARK reduced its stake in Iridium Communications Inc (NASDAQ:IRDM) by 49,041 shares, totaling $818,494. This continues a pattern of selling IRDM shares over the past week.
Other notable sales included 111,470 shares of Veracyte Inc (NASDAQ:VCYT) for $4,444,308, and smaller reductions in Guardant Health Inc (NASDAQ:GH), Natera Inc (NASDAQ:NTRA), and Solstice Advanced Materials Inc (NASDAQ:SOLS).
These moves reflect ARK's ongoing strategy of reallocating capital towards high-conviction growth opportunities while trimming positions in companies where they see limited upside. Investors will be watching closely to see how these trades align with broader market trends and ARK's long-term vision.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.